Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS

[1] Forner A(2008)Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma Hepatology 47 97-104

[2] Vilana R(2014)CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features Radiology 273 30-50

[3] Ayuso C(2019)Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? Eur Radiol 29 1724-1732

[4] Choi JY(2010)Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma Radiology 255 459-466

[5] Lee JM(2016)Diagnostic criteria for hepatocellular carcinoma 3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging J Hepatol 64 1099-1107

[6] Sirlin CB(2014)Assessing patients with hepatocellular carcinoma meeting the Milan criteria: is liver 3 tesla MR with gadoxetic acid necessary in addition to liver CT? J Magn Reson Imaging 39 842-852

[7] Joo I(2015)Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival Gastroenterology 148 1371-1382

[8] Lee JM(2009)Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma J Gastroenterol 44 793-798

[9] Lee DH(2012)Diffusion-weighted MR imaging for liver lesion characterization: a critical look Radiology 262 378-380

[10] Jeon JH(2011)New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases J Hepatol 55 126-132

[1] Forner A(2008)Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma Hepatology 47 97-104

[2] Vilana R(2014)CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features Radiology 273 30-50

[3] Ayuso C(2019)Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? Eur Radiol 29 1724-1732

[4] Choi JY(2010)Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma Radiology 255 459-466

[5] Lee JM(2016)Diagnostic criteria for hepatocellular carcinoma 3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging J Hepatol 64 1099-1107

[6] Sirlin CB(2014)Assessing patients with hepatocellular carcinoma meeting the Milan criteria: is liver 3 tesla MR with gadoxetic acid necessary in addition to liver CT? J Magn Reson Imaging 39 842-852

[7] Joo I(2015)Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival Gastroenterology 148 1371-1382

[8] Lee JM(2009)Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma J Gastroenterol 44 793-798

[9] Lee DH(2012)Diffusion-weighted MR imaging for liver lesion characterization: a critical look Radiology 262 378-380

[10] Jeon JH(2011)New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases J Hepatol 55 126-132